产品
  • 产品
  • 供应商
  • 采购
  • 资讯
  • 会展
首页 制药产品大全 原料药 格列齐特Gliclazide

格列齐特Gliclazide

2024-10-24
21187-98-4
美国药典,欧洲药典
药用级

产品详情

格列齐特Gliclazide
心血管系统用药
21187-98-4
美国药典,欧洲药典
药用级
格列齐特Gliclazide,原料药,心血管系统用药
0
北美洲,中/南美洲,西欧,东欧,大洋洲,亚洲,中东,非洲

产品描述

-

补充信息:
格列齐特(Gliclazide)是一种口服降糖药,分子式为C15H21N3O3S,CAS号为21187-98-4。它属于磺脲类药物,主要用于治疗2型糖尿病,通过刺激胰腺β细胞分泌胰岛素来降低血糖。格列齐特具有较好的降糖效果,且低血糖风险较低,通常作为单药或联合其他降糖药物使用。其缓释制剂可延长作用时间,提高患者依从性。使用时应遵医嘱,注意监测血糖,避免与其他降糖药物或酒精同时使用。
华中药业有限公司
访问店铺
注册资本
公司地址
联系人

公司简介

                                                                                  BriefHPC is the representative of API manufacturers in China in the history. The product portfolio includes APIs for human and veterinary use, Vitamins, food, feed and nutrition products.HPC provide APIs from the most qualified and well-known Chinese manufacturers with current GMP and COS documents and FDA certificates. HPC Vitamins can be provided with KOSHER and HALAL certifications.HPC support the Chinese manufacturers in the whole process of documentation and development to facilitate generic drug market entry prior to expiration of the patent since 2000. Moreover, HPC assist the foreign clients to find reliable manufacturers in China who meet their requirements and help them in the auditing.HPC provides logistic and distribution services for clients alll over the world. HPC established cross-border e-commerce business division. In 2023, health care products and OTC products of Honzo Pharma., a century-old  Pharmaceutical company, entered the Chinese market through the HPC platform.HPC, trade service.HPC, you choice.
业务类型:
成立日期:
年营业额:
主营产品类别: